Clinical Trial Update: A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103) [Phase 1]

View source ↗

Summary

Phase 1 functional MRI study in overweight and obese men, sponsored by Merck Sharp & Dohme LLC, and listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 1 | Status: COMPLETED